News
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...
Kite Pharma will buy Interius BioTherapeutics for $350 million in cash to add an in vivo CAR‑T platform that creates T‑cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback